Before pharmacogenomics, healthcare providers used a “one size fits all” approach to treating individuals.
Now it has the potential to transform healthcare through, avoidance of drug side effects.
Metabolic Validation testing can determine whether you are a poor metabolizer, intermediate or ultra-rapid metabolizer.
The goal of metabolic validation testing (pharmacogenetic testing), is to have drug treatments that are specific to each person.
Today, healthcare providers have the ability to use genomic information to tailor medicine and/or treatments to the individual, and personalize their care.
Nurses are typically on the front line communicating with the patient, family and other healthcare professionals. It is important that they understand the impact and effectiveness of personalized medicine.
A nurse can play a big role in personalized medicine. They can help facilitate drug selection or dosage in treatment of an individual.
In 2007, the FDA revised the label on the common blood-thinning drug warfarin (Coumadin) to explain that a person’s genetic make-up might influence response to the drug. Warfarin and many other drugs now have a Black Box Warning to let healthcare professionals know patients may need to receive a lower dose or to change what medications they are receiving to avoid adverse drug reactions.
For more information on Metabolic Validation, contact:
PGx Medical
Individualized Care – Personalized Medicine
info@pgxmed.com
405-509-5112